Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Triptorelin acetate Triptorelin acetate 140194-24-7 C64H82N18O13.C2H4O2
1'-Hydroxybufuralol 1'-Hydroxybufuralol 57704-16-2 C16H23NO3
Ensitrelvir Ensitrelvir 2647530-73-0 C22H17ClF3N9O2
BLU-945 BLU-945 2660250-10-0 C28H37FN6O3S
HEXANOYL COENZYME A TRILITHIUM SALT HEXANOYL COENZYME A TRILITHIUM SALT 103476-19-3 C27H47LiN7O17P3S
CIS-7, CIS-11-HEXADECADIENYL ACETATE CIS-7, CIS-11-HEXADECADIENYL ACETATE 52207-99-5 C18H32O2
Disitamab Vedotin Disitamab Vedotin 2136633-23-1
CINACALCET CINACALCET 226256-56-0 C22H22F3N
NP-G2-044 NP-G2-044 1807454-59-6 C21H16F3N3O2
Regorafenib (Hydrochloride) Regorafenib (Hydrochloride) 835621-07-3 C21H16Cl2F4N4O3
Cariprazine hydrochloride Cariprazine hydrochloride 1083076-69-0 C21H33Cl3N4O
GRT6005 GRT6005 863513-91-1 C24H27FN2O
AZD 3759 AZD 3759 1626387-80-1 C22H23ClFN5O3
DASA-58 DASA-58 1203494-49-8 C19H23N3O6S2
Ulixertinib hydrochloride Ulixertinib hydrochloride 1956366-10-1 C21H23Cl3N4O2
SCH 446132 SCH 446132 569351-91-3 C22H28BrN5O5
LGD-3303 LGD-3303 917891-35-1 C16H14ClF3N2O
Ripretinib Ripretinib 1442472-39-0 C24H21BrFN5O2
CPI-444 CPI-444 1202402-40-1 C20H21N7O3
SR9009 SR9009 1379686-30-2 C20H24ClN3O4S
YK11 YK11 431579-34-9 C25H34O6
ODM-201 ODM-201 1297538-32-9 C19H19ClN6O2
Ixazomib citrate Ixazomib citrate 1239908-20-3 C20H23BCl2N2O9
IDO-IN-2 IDO-IN-2 1668565-74-9 C29H35N7O
Fezolinetant Fezolinetant 1629229-37-3 C16H15FN6OS
EC330 EC330 2016795-77-8 C30H32F2O2
GDC-0077 GDC-0077 2060571-02-8 C18H19F2N5O4
GNE140 GNE140 2003234-63-5 C25H23ClN2O3S2
CA-4948 CA-4948 1801343-74-7 C21H19N7O3
Calcium 2-oxoglutarate Calcium 2-oxoglutarate 71686-01-6 C5H8CaO5
Remibrutinib Remibrutinib 1787294-07-8 C27H27F2N5O3
APREMILAST (PDE inhibitor) APREMILAST (PDE inhibitor)
RU.521 RU.521 2262452-06-0 C19H12Cl2N4O3
Talabostat isomer mesylate Talabostat isomer mesylate C??H??BN?O?S
(±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride (±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride 60398-91-6 C16H24ClNO2
GUVACINE HYDROCHLORIDE GUVACINE HYDROCHLORIDE 6027-91-4 C6H10ClNO2
SB218078 SB218078 135897-06-2 C24H15N3O3
Azacosterol dihydrochloride Azacosterol dihydrochloride 1249-84-9 C25H45ClN2O
Theodrenaline Theodrenaline 13460-98-5 C17H21N5O5
SDZ 33-243 SDZ 33-243 83602-41-9 C64H113N11O13
BMS-502 BMS-502 2407854-18-4
Furamidine dihydrochloride Furamidine dihydrochloride 55368-40-6 C18H16N4O
LXG6403 LXG6403 315705-04-5 C15H15N5OS2
GJG057 GJG057 2761767-18-2 C21H21F5N4O2
Dexrazoxane hydrochloride Dexrazoxane hydrochloride 149003-01-0 C11H16N4O4.ClH
Tafamidis Tafamidis 594839-88-0 C14H7Cl2NO3
Deoxygalactonojirimycin Hydrochloride Deoxygalactonojirimycin Hydrochloride 75172-81-5 C6H13NO4.ClH
MK-4827 (tosylate) MK-4827 (tosylate) 1038915-73-9 C26H28N4O4S
Seclidemstat Seclidemstat 1423715-37-0 C20H23ClN4O4S
SLU-PP-332 SLU-PP-332 303760-60-3 C18H14N2O2
H2N-TDFTLTI-OH H2N-TDFTLTI-OH C37H59N7O13
Nerandomilast Nerandomilast 1423719-30-5 C20H26ClN6O2S-
Pemigatinib Pemigatinib 1513857-77-6 C24H27F2N5O4
5-Aminouridine 5-Aminouridine 2149-76-0 C9H13N3O6
B7-33 2mg/5mg/10mg B7-33 2mg/5mg/10mg 1818415-56-3 C131H229N41O36S
N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl 1219976-29-0 C10H17ClN4O2
Clascoterone Clascoterone 19608-29-8 C24H34O5
XL518 XL518 934660-93-2 C21H21F3IN3O2
Tucatinib Tucatinib 937263-43-9 C26H24N8O2
Peficitinib Peficitinib 944118-01-8 C18H22N4O2
FMoc-Val-Cit-PAB-MMAE FMoc-Val-Cit-PAB-MMAE 1350456-56-2 C73H104N10O14
Ivosidenib Ivosidenib 1448347-49-6 C28H22ClF3N6O3
GNE-140 (racemate) GNE-140 (racemate) 1802977-61-2 C25H23ClN2O3S2
PF-06882961 PF-06882961 2230198-02-2 C31H30FN5O4
Delgocitinib Delgocitinib 1263774-59-9 C16H18N6O
Selpercatinib Selpercatinib 2152628-33-4 C29H31N7O3
Osilodrostat phosphate Osilodrostat phosphate 1315449-72-9 C13H13FN3O4P
Etrasimod arginine Etrasimod arginine 1206123-97-8 C32H40F3N5O5
JAK-IN-3 JAK-IN-3 1400876-94-9 C18H20N4O3
Tetraacetylphytosphingosine Tetraacetylphytosphingosine 13018-48-9 C26H47NO7
GNF362 GNF362 1003019-41-7 C22H21F3N6
DPO-1 DPO-1 43077-30-1 C22H29OP
Berotralstat hydrochloride Berotralstat hydrochloride 1809010-52-3 C30H27ClF4N6O
IA-14069 IA-14069 2271216-04-5 C20H15ClF2O4
APG-2449 APG-2449 2196186-84-0 C33H42ClN5O4S
nitrification inhibitor nitrification inhibitor
FHD-286 FHD-286 2671128-05-3 C24H30N6O6S2
Maytansinol Maytansinol 57103-68-1 C28H37ClN2O8
Pixantrone Dimaleate Pixantrone Dimaleate 144675-97-8 C21H23N5O6
HRX-0215 HRX-0215 2369583-33-3 C21H17F2N5O3S
PE 22-28 PE 22-28 1801959-12-5 C35H55N11O9
turbinaric acid turbinaric acid 56882-00-9 C27H44O2
Melanotan II acetate Melanotan II acetate
OTUB2-IN-1 OTUB2-IN-1
Gimatecan HCl Gimatecan HCl
Alisol C 23-acetate Alisol C 23-acetate 26575-93-9 C32H48O6
(E,Z)-2,13-Octadecadienyl acetate (E,Z)-2,13-Octadecadienyl acetate 86252-65-5 C20H36O2
Crisaborole Crisaborole 906673-24-3 C14H10BNO3
Donafenib Donafenib 1130115-44-4 C21H16ClF3N4O3
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine 873436-91-0 C18H21IN6O2S
(+)-Cloprostenol isopropyl ester (+)-Cloprostenol isopropyl ester 157283-66-4 C25H35ClO6
Gefapixant Gefapixant 1015787-98-0 C14H19N5O4S
Quizartinib hydrochloride Quizartinib hydrochloride 1132827-21-4 C29H33ClN6O4S
Omadacycline Omadacycline 389139-89-3 C29H40N4O7
Sarecycline Hydrochloride Sarecycline Hydrochloride 1035979-44-2 C24H30ClN3O8
Relugolix Relugolix 737789-87-6 C29H27F2N7O5S
 PTP Inhibitor V, PHPS1 PTP Inhibitor V, PHPS1 314291-83-3 C21H15N5O6S
ERDAFITINIB ERDAFITINIB 1346242-81-6 C25H30N6O2
CPI 360 CPI 360 1802175-06-9 C25H31N3O4
Tradipitant Tradipitant 622370-35-8 C28H16ClF6N5O
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.